Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry

Date: December 28, 2012
Pages: 219
Price:
US$ 3,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MC66F4AB614EN
Leaflet:

Download PDF Leaflet

Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData’s new report, “Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Middle East and Africa In Vitro Diagnostics Market – South Africa, Israel and Saudi Arabia.. The report provides value (USD million) data for all the market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Countries covered include South Africa, Israel and Saudi Arabia..
  • Market size and company share data for In Vitro Diagnostics market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories and countries.
  • Global corporate-level profiles of key companies operating within the Middle East and Africa In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Becton, Dickinson and Company, Ortho-Clinical Diagnostics Inc., Mindray Medical International Limited, Bio-Rad Laboratories, Inc., Alere Inc., DiaSorin S.p.A, Sysmex Corporation and Qiagen N.V.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Middle East and Africa In Vitro Diagnostics competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 IN VITRO DIAGNOSTICS IN MIDDLE EAST AND AFRICA

3.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
3.2 In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics, Middle East and Africa, Company share (2010-2011)

4 IN VITRO DIAGNOSTICS IN SOUTH AFRICA

4.1 In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
4.2 In Vitro Diagnostics, South Africa, Distribution Share (2010-2011)
  4.2.1 Clinical Chemistry, South Africa, Distribution Share (2010-2011)
  4.2.2 Genetic Testing, South Africa, Distribution Share (2010-2011)
  4.2.3 Haematology, South Africa, Distribution Share (2010-2011)
  4.2.4 Histology And Cytology, South Africa, Distribution Share (2010-2011)
  4.2.5 Immuno Chemistry, South Africa, Distribution Share (2010-2011)
  4.2.6 Infectious Immunology, South Africa, Distribution Share (2010-2011)
  4.2.7 Microbiology Culture, South Africa, Distribution Share (2010-2011)
4.3 In Vitro Diagnostics, South Africa, Company Share (2010-2011)
  4.3.1 In Vitro Diagnostics, South Africa, Company Share (2010-2011)
  4.3.2 Clinical Chemistry, South Africa, Company Share (2010-2011)
  4.3.3 Genetic Testing, South Africa, Company Share (2010-2011)
  4.3.4 Haematology, South Africa, Company Share (2010-2011)
  4.3.5 Histology And Cytology, South Africa, Company Share (2010-2011)
  4.3.6 Immuno Chemistry, South Africa, Company Share (2010-2011)
  4.3.7 Infectious Immunology, South Africa, Company Share (2010-2011)
  4.3.8 Microbiology Culture, South Africa, Company Share (2010-2011)

5 IN VITRO DIAGNOSTICS IN ISRAEL

5.1 In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, 2004-2018
5.2 In Vitro Diagnostics, Israel, Distribution Share (2010-2011)
  5.2.1 Clinical Chemistry, Israel, Distribution Share (2010-2011)
  5.2.2 Genetic Testing, Israel, Distribution Share (2010-2011)
  5.2.3 Haematology, Israel, Distribution Share (2010-2011)
  5.2.4 Histology And Cytology, Israel, Distribution Share (2010-2011)
  5.2.5 Immuno Chemistry, Israel, Distribution Share (2010-2011)
  5.2.6 Infectious Immunology, Israel, Distribution Share (2010-2011)
  5.2.7 Microbiology Culture, Israel, Distribution Share (2010-2011)
5.3 In Vitro Diagnostics, Israel, Company Share (2010-2011)
  5.3.1 In Vitro Diagnostics, Israel, Company Share (2010-2011)
  5.3.2 Clinical Chemistry, Israel, Company Share (2010-2011)
  5.3.3 Genetic Testing, Israel, Company Share (2010-2011)
  5.3.4 Haematology, Israel, Company Share (2010-2011)
  5.3.5 Histology And Cytology, Israel, Company Share (2010-2011)
  5.3.6 Immuno Chemistry, Israel, Company Share (2010-2011)
  5.3.7 Infectious Immunology, Israel, Company Share (2010-2011)
  5.3.8 Microbiology Culture, Israel, Company Share (2010-2011)

6 IN VITRO DIAGNOSTICS IN SAUDI ARABIA

6.1 In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
6.2 In Vitro Diagnostics, Saudi Arabia, Distribution Share (2010-2011)
  6.2.1 Clinical Chemistry, Saudi Arabia, Distribution Share (2010-2011)
  6.2.2 Genetic Testing, Saudi Arabia, Distribution Share (2010-2011)
  6.2.3 Haematology, Saudi Arabia, Distribution Share (2010-2011)
  6.2.4 Histology And Cytology, Saudi Arabia, Distribution Share (2010-2011)
  6.2.5 Immuno Chemistry, Saudi Arabia, Distribution Share (2010-2011)
  6.2.6 Infectious Immunology, Saudi Arabia, Distribution Share (2010-2011)
  6.2.7 Microbiology Culture, Saudi Arabia, Distribution Share (2010-2011)
6.3 In Vitro Diagnostics, Saudi Arabia, Company Share (2010-2011)
  6.3.1 In Vitro Diagnostics, Saudi Arabia, Company Share (2010-2011)
  6.3.2 Clinical Chemistry, Saudi Arabia, Company Share (2010-2011)
  6.3.3 Genetic Testing, Saudi Arabia, Company Share (2010-2011)
  6.3.4 Haematology, Saudi Arabia, Company Share (2010-2011)
  6.3.5 Histology And Cytology, Saudi Arabia, Company Share (2010-2011)
  6.3.6 Infectious Immunology, Saudi Arabia, Company Share (2010-2011)
  6.3.7 Immuno Chemistry, Saudi Arabia, Company Share (2010-2011)
  6.3.8 Microbiology Culture, Saudi Arabia, Company Share (2010-2011)

7 OVERVIEW OF KEY COMPANIES IN MIDDLE EAST AND AFRICA IN VITRO DIAGNOSTICS MARKET

7.1 F. Hoffmann-La Roche Ltd.
  7.1.1 Company Overview
  7.1.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.2 Siemens Healthcare
  7.2.1 Company Overview
  7.2.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.3 Abbott Laboratories
  7.3.1 Company Overview
  7.3.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.4 Beckman Coulter, Inc.
  7.4.1 Company Overview
  7.4.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.5 bioMerieux S.A.
  7.5.1 Company Overview
  7.5.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.6 Becton, Dickinson and Company
  7.6.1 Company Overview
  7.6.2 Share in the Middle East and Africa In Vitro Diagnostics Market
7.7 Ortho-Clinical Diagnostics Inc.
  7.7.1 Company Overview
7.8 DiaSorin S.p.A
  7.8.1 Company Overview
7.9 Mindray Medical International Limited
  7.9.1 Company Overview
7.10 Bio-Rad Laboratories, Inc.
  7.10.1 Company Overview
7.11 Alere Inc.
  7.11.1 Company Overview
7.12 Sysmex Corporation
  7.12.1 Company Overview
7.13 Qiagen N.V.
  7.13.1 Company Overview
7.14 Horiba, Ltd.
  7.14.1 Company Overview
7.15 Thermo Fisher Scientific Inc.
  7.15.1 Company Overview
7.16 Grifols, S.A.
  7.16.1 Company Overview
7.17 Gen-Probe Incorporated
  7.17.1 Company Overview
7.18 Phadia AB
  7.18.1 Company Overview
7.19 PerkinElmer, Inc.
  7.19.1 Company Overview
7.20 Life Technologies Corporation
  7.20.1 Company Overview
7.21 Diagnostica Stago, Inc.
  7.21.1 Company Overview
7.22 Hologic, Inc.
  7.22.1 Company Overview
7.23 Chembio Diagnostics, Inc.
  7.23.1 Company Overview
7.24 Immucor, Inc.
  7.24.1 Company Overview
7.25 Sysmex Corporation
  7.25.1 Company Overview
7.26 Abbott Laboratories
  7.26.1 Company Overview
7.27 Becton, Dickinson and Company
  7.27.1 Company Overview

8 IN VITRO DIAGNOSTICS MARKET PIPELINE PRODUCTS

8.1 Clinical Chemisty Market Pipeline Products
8.2 Immuno Chemistry Market Pipeline Products
8.3 Haematology Market Pipeline Products
8.4 Infectious Immunology Market Pipeline Products
8.5 Microbiology Culture Market Pipeline Products
8.6 Histology And Cytology Market Pipeline Products
8.7 Genetic Testing Market Pipeline Products

9 FINANCIAL DEALS LANDSCAPE

9.1 Acquisition
  9.1.1 Micromedic Acquires 33% Stake In BioMarCare, Cancer Diagnostics Company
9.2 Partnerships
  9.2.1 Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
  9.2.2 BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System
  9.2.3 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
  9.2.4 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
  9.2.5 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
  9.2.6 BioDot Enters Into Co-Marketing Agreement With JOT Automation
  9.2.7 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
  9.2.8 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
  9.2.9 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
  9.2.10 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
  9.2.11 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
  9.2.12 CML HealthCare Enters Into Agreement With MaRS Innovation
  9.2.13 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
  9.2.14 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
  9.2.15 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
  9.2.16 NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
  9.2.17 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
  9.2.18 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
  9.2.19 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
  9.2.20 BioView Enters Into Co-Development Agreement With ScreenCell For Circulating Tumor Cell Analysis Technology
  9.2.21 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
  9.2.22 Merck Serono Forms Joint Venture With Compugen To Establish New Biomarker Company
  9.2.23 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
  9.2.24 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
  9.2.25 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
  9.2.26 One Lambda Enters Into Co-Marketing Agreement With CellTrend
  9.2.27 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
  9.2.28 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
  9.2.29 Gemoscan Enters Into Licensing Agreement With Haemodek For Hemocode Food Intolerance System
  9.2.30 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
  9.2.31 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
  9.2.32 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
  9.2.33 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
  9.2.34 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
  9.2.35 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
  9.2.36 LipoScience Enters Into Licensing Agreement With Cleveland Clinic
  9.2.37 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
  9.2.38 Sysmex Extends Distribution Agreement With Roche
  9.2.39 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
  9.2.40 BGN Technologies Enters Into Licensing Agreement With Lauren Sciences For V-Smart Technology
  9.2.41 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
  9.2.42 LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology
  9.2.43 Yissum Research Development Company Enters Into Licensing Agreement With BioConnections For Commercialization Of Kits
  9.2.44 RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease

10 RECENT DEVELOPMENTS

10.1 Strategy And Business Planning
  10.1.1 Nov 20, 2012: PerkinElmer Establishes New Direct Operations In Southern Africa
  10.1.2 Jul 24, 2012: Life Technologies And SATuRN Collaborate To Increase Access To HIV Testing In Africa
10.2 Research And Development
  10.2.1 Mar 14, 2012: GE Healthcare And Intel To Establish Companies’ First Joint Technology Evaluation Laboratory In Israel
10.3 Government and Public Interest
  10.3.1 Nov 20, 2012: New Test For Tuberculosis Could Improve Treatment, Prevent Deaths In Southern Africa: Study
  10.3.2 Jan 19, 2012: Mindray Medical To Exhibit At Arab Health 2012 In Dubai
  10.3.3 Jan 19, 2012: Source BioScience To Attend Arab Health Conference In Dubai
10.4 Product News
  10.4.1 Jun 28, 2012: IBM Recommends Strategy To Help Improve Cervical Cancer Screening And Treatment In Kenya

11 APPENDIX

11.1 Definitions of Markets Covered in the Report
  11.1.1 In Vitro Diagnostics
11.2 Research Methodology
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panels
11.8 GlobalData Consulting
11.9 Currency Conversion
11.10 Contact Us
11.11 Disclaimer

LIST OF TABLES

Table 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: Diagnostic Imaging, Middle East and Africa, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Middle East and Africa, Company share by Revenue ($m), USD Constant, 2010-2011
Table 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Table 8: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Haematology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 17: In Vitro Diagnostics, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Clinical Chemistry, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Genetic Testing, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Haematology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Histology And Cytology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Immuno Chemistry, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 23: Infectious Immunology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 24: Microbiology Culture, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 25: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, 2004-2018
Table 26: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 27: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 28: Clinical Chemistry, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Genetic Testing, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Haematology, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Histology And Cytology, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Immuno Chemistry, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Infectious Immunology, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Microbiology Culture, Israel, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: In Vitro Diagnostics, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Clinical Chemistry, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Genetic Testing, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Haematology, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Histology And Cytology, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Immuno Chemistry, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Infectious Immunology, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Microbiology Culture, Israel, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 43: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
Table 44: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 45: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 46: Clinical Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 47: Genetic Testing, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Haematology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Histology And Cytology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Immuno Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Infectious Immunology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Microbiology Culture, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 53: In Vitro Diagnostics, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Clinical Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Genetic Testing, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 56: Haematology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Histology And Cytology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Infectious Immunology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Immuno Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Microbiology Culture, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 61: Clinical Chemisty Market Pipeline Products
Table 62: Immuno Chemistry Market Pipeline Products
Table 63: Haematology Market Pipeline Products
Table 64: Infectious Immunology Market Pipeline Products
Table 65: Microbiology Culture Market Pipeline Products
Table 66: Histology And Cytology Market Pipeline Products
Table 67: Genetic Testing Market Pipeline Products
Table 68: Micromedic Acquires 33% Stake In BioMarCare, Cancer Diagnostics Company
Table 69: Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
Table 70: BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System
Table 71: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 72: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 73: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 74: BioDot Enters Into Co-Marketing Agreement With JOT Automation
Table 75: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 76: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 77: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 78: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 79: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Table 80: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 81: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 82: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 83: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 84: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Table 85: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 86: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 87: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 88: BioView Enters Into Co-Development Agreement With ScreenCell For Circulating Tumor Cell Analysis Technology
Table 89: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 90: Merck Serono Forms Joint Venture With Compugen To Establish New Biomarker Company
Table 91: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 92: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 93: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 94: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 95: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 96: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 97: Gemoscan Enters Into Licensing Agreement With Haemodek For Hemocode Food Intolerance System
Table 98: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 99: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 100: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
...

LIST OF FIGURES

Figure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics, Middle East and Africa, Cross-Category Analysis, 2004-2018
Figure 4: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 5: In Vitro Diagnostics, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 6: In Vitro Diagnostics, Middle East and Africa, Company share (%), 2011
Figure 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Figure 8: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: In Vitro Diagnostics, South Africa, Company Share (%), 2011
Figure 11: Clinical Chemistry, South Africa, Company Share (%), 2011
Figure 12: Genetic Testing, South Africa, Company Share (%), 2011
Figure 13: Haematology, South Africa, Company Share (%), 2011
Figure 14: Histology And Cytology, South Africa, Company Share (%), 2011
Figure 15: Immuno Chemistry, South Africa, Company Share (%), 2011
Figure 16: Infectious Immunology, South Africa, Company Share (%), 2011
Figure 17: Microbiology Culture, South Africa, Company Share (%), 2011
Figure 18: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, 2004-2018
Figure 19: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 20: In Vitro Diagnostics, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 21: In Vitro Diagnostics, Israel, Company Share (%), 2011
Figure 22: Clinical Chemistry, Israel, Company Share (%), 2011
Figure 23: Genetic Testing, Israel, Company Share (%), 2011
Figure 24: Haematology, Israel, Company Share (%), 2011
Figure 25: Histology And Cytology, Israel, Company Share (%), 2011
Figure 26: Immuno Chemistry, Israel, Company Share (%), 2011
Figure 27: Infectious Immunology, Israel, Company Share (%), 2011
Figure 28: Microbiology Culture, Israel, Company Share (%), 2011
Figure 29: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
Figure 30: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: In Vitro Diagnostics, Saudi Arabia, Company Share (%), 2011
Figure 33: Clinical Chemistry, Saudi Arabia, Company Share (%), 2011
Figure 34: Genetic Testing, Saudi Arabia, Company Share (%), 2011
Figure 35: Haematology, Saudi Arabia, Company Share (%), 2011
Figure 36: Histology And Cytology, Saudi Arabia, Company Share (%), 2011
Figure 37: Infectious Immunology, Saudi Arabia, Company Share (%), 2011
Figure 38: Immuno Chemistry, Saudi Arabia, Company Share (%), 2011
Figure 39: Microbiology Culture, Saudi Arabia, Company Share (%), 2011
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011
Figure 41: Siemens Healthcare, Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011
Figure 42: Abbott Laboratories, Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011
Figure 43: Beckman Coulter, Inc., Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011
Figure 44: bioMerieux S.A., Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011
Figure 45: Becton, Dickinson and Company, Company Share (%), Middle East and Africa In Vitro Diagnostics Market, 2011

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Ortho-Clinical Diagnostics Inc.
DiaSorin S.p.A
Mindray Medical International Limited
Bio-Rad Laboratories, Inc.
Alere Inc.
Sysmex Corporation
Qiagen N.V.
Horiba, Ltd.
Thermo Fisher Scientific Inc.
Grifols, S.A.
Gen-Probe Incorporated
Phadia AB
PerkinElmer, Inc.
Life Technologies Corporation
Diagnostica Stago, Inc.
Hologic, Inc.
Chembio Diagnostics, Inc.
Immucor, Inc.
Sysmex Corporation
Abbott Laboratories
Becton, Dickinson and Company

Ask Your Question

Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: